Market Research Report
Medical Microneedle Diagnostics
|Medical Microneedle Diagnostics|
Published: January 4, 2022
Greystone Research Associates
Content info: 125 Pages
Delivery time: 1-2 business days
Microneedle technology is attaining commercial viability at a time when healthcare providers are faced with new challenges as they assess ways to incorporate companion diagnostics into their practice areas. Microneedle technology has the potential to address the growing trend toward point of care diagnostics and ambulatory patient monitoring by allowing the precise detection of biomarkers and analytes in fluids and tissues located below the skin. To succeed, developers must refine the techniques available and in development for sampling very small quantities and/or concentrations of analytes and biomarkers and advance the design integration of microneedles into commercially viable diagnostic platform.